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ABSTRACT
The receptor(s) for porcine sapelovirus (PSV), which causes diarrhea, pneumonia, polioencephalomyelitis, and reproductive
disorders in pigs, remains largely unknown. Given the precedent for other picornaviruses which use terminal sialic acids (SAs) as
receptors, we examined the role of SAs in PSV binding and infection. Using a variety of approaches, including treating cells with
a carbohydrate-destroying chemical (NaIO4), mono- or oligosaccharides (N-acetylneuraminic acid, galactose, and 6=-sialyllac-
tose), linkage-specific sialidases (neuraminidase and sialidase S), lectins (Maakia amurensis lectin and Sambucus nigra lectin),
proteases (trypsin and chymotrypsin), and glucosylceramide synthase inhibitors (DL-threo-1-phenyl-2-decanoylamino-3-mor-
pholino-1-propanol and phospholipase C), we demonstrated that PSV could recognize 2,3-linked SA on glycolipids as a recep-
tor. On the other hand, PSVs had no binding affinity for synthetic histo-blood group antigens (HBGAs), suggesting that PSVs
could not use HBGAs as receptors. Depletion of cell surface glycolipids followed by reconstitution studies indicated that GD1a
ganglioside, but not other gangliosides, could restore PSV binding and infection, further confirming 2,3-linked SA on GD1a as
a PSV receptor. Our results could provide significant information on the understanding of the life cycle of sapelovirus and other
picornaviruses. For the broader community in the area of pathogens and pathogenesis, these findings and insights could con-
tribute to the development of affordable, useful, and efficient drugs for anti-sapelovirus therapy.
IMPORTANCE
The porcine sapelovirus (PSV) is known to cause enteritis, pneumonia, polioencephalomyelitis, and reproductive disorders in
pigs. However, the receptor(s) that the PSV utilizes to enter host cells remains largely unknown. Using a variety of approaches,
we showed that2,3-linked terminal sialic acid (SA) on the cell surface GD1a ganglioside could be used for PSV binding and
infection as a receptor. On the other hand, histo-blood group antigens also present in the cell surface carbohydrates could not be
utilized as PSV receptors for binding and infection. These findings should contribute to the understanding of the sapelovirus life
cycle and to the development of affordable, useful and efficient drugs for anti-sapelovirus therapy.
Viral infections are initiated by binding of a virus particle tospecific receptors at the surface of host cells (1).Monosaccha-
ride sialic acids (SAs), a large family of neuraminic acid deriva-
tives, decorate all eukaryotic cell surfaces, usually at the termini of
glycans attached as glycoproteins, glycosphingolipids, and the
proteoglycan keratin sulfate (2). Since SA on the cell surface is
readily accessible, SA itself often serves as a receptor for a signifi-
cant number of enveloped and nonenveloped viruses. Represen-
tatives from at least nine different virus families use SA as recep-
tors: Picornaviridae (3), Caliciviridae (4), Orthomyxoviridae (5),
Paramyxoviridae (6), Coronaviridae (7), Reoviridae (8), Parvoviri-
dae (9), Polyomaviridae (10), and Adenoviridae (11). Most SAs as
virus receptors are terminal SAs attached to the underlying
sugar chain by an 2,3 linkage or an 2,6 linkage. This may
contribute to virus tissue tropism, pathogenesis, and host spec-
ificity (1, 12).
Viruses within the Picornaviridae family are small, nonenvel-
oped viruses containing single-stranded, positive-sense RNA ge-
nomes. Picornaviruses can cause a range of infections, including
intestinal, respiratory, neurological, cardiac, hepatic, mucocuta-
neous, and systemic diseases with various severities in humans
and animals (13). Porcine sapelovirus (PSV) appears to be most
closely related to simian picornavirus type 2 (simian sapelovirus)
and duck picornavirus TW90Ak (avian sapelovirus) (14, 15). Sim-
ian, avian, and porcine picornaviruses have been recently assigned
as members of a new picornavirus genus, Sapelovirus (14, 15).
PSV infections in the field and experimental infections in orally
inoculated pigs may cause either asymptomatic or symptomatic
infections. In the latter case, infection is associated with a wide
spectrum of disorders, including diarrhea, pneumonia, polioen-
cephalomyelitis, and reproductive disorders (16–18). Pigs are the
only species known to be naturally susceptible to PSV, although
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pregnant guinea pigs experimentally infected with PSV developed
placental lesions (17, 19). Transmission of PSV is primarily
through the fecal-oral route (17), but aerosol infectionmay lead to
lung infection (20). PSVs are readily cultivated in cell cultures of
porcine origin, including primary or secondary pig kidney cell
cultures and the IB-RS-2 pig kidney cell line (21). Among cell lines
from other species, PSVs can replicate in a baby hamster kidney
(BHK21) cell line but not in human cervical cancer (HeLa) or
African greenmonkey kidney (Vero) cell lines (21). PSVs has been
isolated from the feces of healthy or diarrheic pigs, from the cen-
tral nervous system of pigs with polioencephalomyelitis, from the
pig lung tissues with pneumonia, or from the tissues of stillborn,
aborted, or mummified fetuses (16, 17). PSVs induce unique type
II cytopathic effects (CPE) characterized by pyknotic nuclei and
highly granular and eosinophilic cytoplasm with uneven protru-
sions in coverslip cultures stained with hematoxylin and eosin
(22).
Although PSV is believed to be an important pathogen due to
its wide distribution and high prevalence (23), the receptor(s) for
PSV or other members of the genus Sapelovirus remains largely
unknown. A large number of viruses, including several picornavi-
ruses, use SAs as receptors. Therefore, the objective of this study
was to determine whether PSV could recognize SAs as receptors.
MATERIALS AND METHODS
Cells and viruses. Porcine kidney LLC-PK and human cervical cancer
HeLa cells (American Type Culture Collection [ATCC]) weremaintained
in Eagle’s minimal essential medium (EMEM) supplemented with 10%
fetal bovine serum (FBS), 100 U/ml of penicillin, and 100 g/ml of strep-
tomycin. Crandall-Reese feline kidney (CRFK) cells, human lung WI-38
fibroblasts, and Madin-Darby canine kidney (MDCK) cells from the
ATCC were grown in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 5% FBS, 100 U/ml of penicillin, and 100 g/ml of
streptomycin. MA-104 cells (ATCC) were cultured in alpha minimum
essentialmedium supplementedwith 5%FBS, 100U/ml of penicillin, and
100 g/ml of streptomycin.
PSV strains (KS05151, KS05152, KS055217, andKS04105) used in this
study were isolated in LLC-PK cells from diarrheic fecal samples from
piglets in South Korea (14, 23). These strains were passaged eight times in
LLC-PK cells, including isolation, adaptation, and triple plaque purifica-
tion. The isolated viruses were confirmed as PSVs by an immunofluores-
cence assay (IFA), reverse transcription-PCR, and transmission electron
microscopy (14). Human influenza A virus H1N1 (A/Puerto Rico/8/34)
(ATCC) was propagated in MDCK cells (24). The F9 strain of feline cali-
civirus (FCV) (ATCC) was propagated in CRFK cells (25). Human rota-
virus (RV) strain Wa (ATCC) was propagated in MA-104 cells (26). En-
terovirus 70 (EV70) strain J670/71 (ATCC)was propagated inWI-38 cells
(3). Coxsackievirus B3 (CVB3) Nancy strain (ATCC) was propagated in
HeLa cells (27).
Reagents and antibodies. Trypsin and chymotrypsin (Sigma-Al-
drich), sodium periodate (NaIO4; Sigma-Aldrich), N-acetylneuraminic
acid (NANA; Fluka), 6=-sialyllactose (6=-SL; GeneChem), galactose (Gal;
Sigma-Aldrich), Maackia amurensis lectin (MAL; Sigma-Aldrich), and
Sambucus nigra lectin (SNL; Sigma-Aldrich) were dissolved in phosphate-
buffered saline (PBS; pH 7.2). Alexa Fluor 594 (AF-594) succinimidyl
ester purchased from Molecular Probes (catalog number A-20004) was
dissolved in dimethyl sulfoxide (DMSO). DL-threo-1-Phenyl-2-decanoyl-
amino-3-morpholino-1-propanol (PDMP; Calbiochem) and phospho-
lipase C (PLC; Calbiochem) were dissolved in ethanol. Other reagents
included [35S]methionine-cysteine (PerkinElmer), neuraminidase (NA;
Sigma-Aldrich), and sialidase S (SS; Prozyme). The following antibodies
were used in this study: anti-PSV capsid monoclonal antibody (MAb)
(kindly provided by M. Dauber, Friedrich Loeffler Institute, Germany),
anti-FCV capsid MAb (Santa Cruz Biotechnology), anti-CVB3 capsid
MAb (Millipore), anti-EV70 capsid MAb (Abcam), anti-RV VP6 protein
MAb (Median Diagnostics), anti-RV VP8* polyclonal antibody, fluores-
cein isothiocyanate (FITC)-conjugated goat anti-mouse IgG antibody
(Santa Cruz Biotechnology), and peroxidase-conjugated goat anti-rabbit
IgG antibody (SantaCruz Biotechnology). Gangliosides (GA,GM1,GM3,
GD1a, GD1b, GT1b, and GQ1b) were purchased from Matreya. LS-tet-
rasaccharide c (LSTc) was obtained from Dextra. Biotin-conjugated oli-
gosaccharides, including Lewis antigens (Lea, Leb, Lex, and Ley), H type,
type A disaccharide, type B disaccharide, type A trisaccharide, type B
trisaccharide, Gal trisaccharide, sLea, and sLex tetrasaccharides, were
purchased from GlycoTech. Horseradish peroxidase (HRP)-conjugated
streptavidin was obtained from Jackson ImmunoResearch Lab.
Cytotoxicity assay. The cytotoxicity of the chemicals used in this
study was determined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-di-
phenyl tetrazolium bromide (MTT) assay (28). Briefly, cells in 96-well
plates were incubated withmedium containing different concentration of
various chemicals for 24 h. After removing the medium, 200 l of MTT
solution was added to each well and incubated for 4 h at 37°C in a CO2
incubator. Afterwards, 150 l of DMSO was read in an enzyme-linked
immunosorbent assay (ELISA) reader with the optical density (OD)mea-
sured at 570 nm. The percent cell viability was calculated using the follow-
ing formula: [(ODsampleODblank)/(ODcontrolODblank)] 100. Non-
toxic concentrations of each chemical were used in this study (data not
shown).
Treatment of cells with chemicals, metabolic inhibitors, and en-
zymes. Sodiumperiodate was used at 1 or 5mMconcentration for 30min
at 4°C. Neuraminidases (NA or SS) were pretreated at 200 mU or 40 mU
for 1 h at 37°C. Lectins (MAL or SNL)were used at 200 or 400gml1 for
1 h at 4°C. Proteases (trypsin or chymotrypsin) were employed at 10 g
ml1 for 30 min at 37°C. Metabolic inhibitors (PDMP or PLC) were used
to pretreat cells at 50 M (3 days at 37°C) or 25 M (30 min at 37°C).
NANAwas preincubated at 20 or 80mM for 1 h at 4°C. After the pretreat-
ment, cells were washed three times with PBS. The binding and infectivity
assays were carried out as described below. Mock and control treatments
were performed at the same time.
Labeling of viruses with [35S]methionine-cysteine. Labeling of vi-
ruses with [35S]methionine-cysteine (PerkinElmer) was carried out as de-
scribed previously, with slight modification (25). Briefly, confluent
monolayers of cells were infectedwith each individual virus at amultiplic-
ity of infection (MOI) of 0.1 PFU/cell for 4 h at 37°C. The medium was
replaced with RPMI 1640 lacking methionine and cysteine (Sigma-Al-
drich). Cells were starved for 2 h and then supplemented with 1 Mbq of
[35S]methionine-cysteine (PerkinElmer) ml1. At 72 h following virus
infection, each labeled virus was purified by cesium chloride (CsCl) den-
sity gradient centrifugation as described below.
Virus purification by CsCl gradient centrifugation. PSVs, FCV,
EV70, RV, and CVB3 grown in each permissible cell line were purified by
CsCl gradient centrifugation. Infected cell cultures harvested at 72 h post-
inoculation were freeze-thawed three times, and cell debris was spun
down at 2,469 g for 10min at 4°C. A total of 500ml of virus-containing
supernatants was concentrated by centrifugation at 245,853 g for 20 h at
4°C using an SW40 rotor (Beckman). The viruses in the pellets were re-
suspended in TNE buffer (50 mM Tris-HCl, 100 mM NaCl, 100 mM
EDTA [pH 7.5]), and then the suspension was layered over 29 to 41%
preformed discontinuous CsCl gradients. After centrifugation at
245,853 g for 20 h at 4°C using an SW40 rotor (Beckman), the banded
virus was collected by puncturing the side of the tube with a needle, di-
luted in distilled water, and further purified by ultracentrifugation at
245,853 g for 20 h at 4°C in an SW40 rotor (Beckman). Purified viruses
were dialyzed into 0.1 M sodium bicarbonate buffer (pH 8.3) for fluores-
cence labeling or in TNE buffer for a radioactivity assay overnight and
then stored in aliquots at 80°C. Analysis of SDS-PAGE-separated,
[35S]methionine-cysteine-labeled viral particles by radiography, Western
blotting, or Coomassie blue staining showed that the label was exclusively
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coupled to the viral capsid protein (data not shown). Plaque assays
showed no loss in infectivity with each labeled virus in each permissible
cell line in comparison with unlabeled virus (data not shown). In a CsCl
gradient purification, the supernatant of anRV strainWa-infected culture
generated two distinct visible bands (29). Each banded virus was analyzed
by the above-listed methods, and virus purified from the fraction with
infectious triple layered particles byCsCl gradient centrifugationwas used
for a radioactivity assay (data not shown).
Labeling of viruses with AF-594. Labeling of viruses with AF-594 was
performed by following the manufacturer’s instructions (Molecular
Probes). Each purified virus (10 mg at 1 mg ml1) in 0.1 M sodium
bicarbonate buffer (pH 8.3) was labeled with a 0.1-fold molar concentra-
tion of AF-594 succinimidyl ester (1 mg at 1 mg ml1 in DMSO). Each
reactionmixturewas vortexed thoroughly for 30 s and incubated for 1 h at
room temperature with continuous stirring. This fluorophore reacts ex-
clusively with free amines, resulting in a stable carboxamide bond, and
contain a seven-atom aminohexanoyl spacer (X), which allows higher
degrees of labeling without functional perturbance of the virus (30). La-
beled virus was repurified with CsCl as described above, dialyzed against
virion buffer, and stored in 2-g aliquots at 20°C (30). Analysis of
SDS-PAGE-separated, AF-594-labeled viral particles by Coomassie blue
staining and Western blotting showed that the label was exclusively cou-
pled to the viral capsid protein (data not shown). The infectivity of each
labeled virus was determined by plaque assay. Plaque assays showed no
loss in infectivity with each labeled virus in permissible cell line in com-
parison with unlabeled virus (data not shown).
Dye-labeled binding assay.Dye-labeled binding assay was performed
with purifiedAF-594-labeled viruses, followed by visualization of subcon-
FIG 1 PSV binding and infection require carbohydrate moieties. (A) The binding of AF-594-labeled PSV (MOI, 1,000 PFU/cell) was examined by confocal
microscopy after pretreating LLC-PK cells with NaIO4. (B) Binding of [
35S]methionine-cysteine-labeled PSV, EV70, FCV, or CVB3 (50,000 cpm) was measured
by liquid scintillation counting after treating cell or not with NaIO4. The levels of bound virus were expressed as a percentage of the value for the mock-treated,
virus-infected control. (C) The effect of NaIO4 pretreatment of permissive cells on the infectivity of PSV (MOI, 1 PFU/cell) was assessed by immunofluorescence
using monoclonal antibody specific for PSV capsid protein at 15 h postinfection. (D) The levels of PSV, EV70, FCV, or CVB3 antigen-positive cells expressed as
percentages of mock-treated, virus-infected cells were quantified from three independent fields of view. All experiments were performed three independent
times. Panels A and C show representative sets of results. The scale bars corresponded to 20 m. Error bars indicated standard deviations (SD) from triplicate
experiments. *, P 0.05; **, P 0.005.
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fluent monolayers of cells grown with or without various inhibitors or
enzymes as described previously, with slight modifications (25). Briefly,
mock-infected or treated cells were inoculated with AF-594-labeled virus
at anMOI of 1,000 and incubated for 5min on ice, followed by incubation
at room temperature for 10 min. Cells were washed extensively with cold
PBS, fixed with 4% formaldehyde, and washed three times with cold PBS.
Dishes were mounted with SlowFade Gold antifade reagent (Invitrogen)
containing 4=,6-diamidino-2-phenylindole (DAPI) solution for nucleus
staining. Infected cells were observed with an LSM 510 confocal micro-
scope and analyzed using LSM software (Carl Zeiss).
Assay for binding of [35S]methionine-cysteine-labeled viruses to
various cell lines. Binding of [35S]methionine-cysteine-labeled viruses to
various cell lines was assayed as described previously, with slight modifi-
cation (25). Briefly, cells (4 104)were plated into 96-well plates. Purified
[35S]methionine-cysteine-labeled viruses (50,000 cpm) were incubated
with cells for 45 min on ice. Cells were washed three times with ice-cold
PBS, followed by cell lysis with 0.1% sodium dodecyl sulfate and 0.1 M
NaOH. Total radioactivity in the cell lysate was determined by liquid
scintillation counting.
Infectivity assay. An infectivity assay of each virus in cells was carried
out as described previously, with slight modification (4). Briefly, conflu-
ent monolayers of cells on the confocal dish were treated with various
inhibitors or enzymes as described above. Mock or treated cells were in-
fected with each virus at an MOI of 1 PFU/cell and incubated at 37°C for
1 h. Cells were washed three times with PBS, and then the maintenance
medium was added. Cells were incubated for 8 h (FCV F9), 9 h (CVB3
Nancy), or 15 h (EV70 J670/71, RV Wa, PSV KS04105) at 37°C prior to
being fixed with 4% formaldehyde in PBS. They were analyzed by immu-
nofluorescence assay as described below.
Immunofluorescence assay. An immunofluorescence assay was per-
formed as previously reported, with slight modification (4). Briefly, fixed
cells on the confocal dish were permeabilized by the addition of 0.2%
Triton X-100, incubated at room temperature for 10 min, and washed
with PBS containing 0.1% newborn calf serum (PBS-NCS). Anti-PSV
capsid (1:40 dilution), anti-FCV capsid (1:100 dilution), anti-EV70 capsid
(1:100 dilution), and anti-RV VP6 protein (1:50 dilution) MAbs were
added. Chamber slides were incubated at 4°C overnight. Cells were then
washed three times with PBS-NCS. FITC-conjugated secondary antibod-
ies (diluted to 1:100) were then added. Nuclei were stained with pro-
pidium iodide, and cells were examined using confocal microscopy.
Synthetic HBGA binding assay. A synthetic oligosaccharide-based
histo-blood group antigens (HBGA) binding assay was carried out as
described previously, with slight modification (4). Briefly, 96-microtiter
plates were coated with viruses or viral proteins. Each synthetic oligosac-
charide-polyacrylamide-biotin conjugate or blocking solution (5% bo-
vine serum albumin in PBS, pH 7.4) was added to each well. Bound oli-
gosaccharide or blocking solution was detected using horseradish
peroxidase-conjugated streptavidin. The signal intensities were visualized
by 3,3=,5,5=-tetramethylbenzidine (TMB; Komabiotech), and the absor-
bance was read at 450 nm in a plate reader. In each step, the plates were
incubated at 37°C for 1 h and washed five times with PBS-Tween 20.
Ganglioside depletion and repletion assay. A ganglioside depletion
and repletion assay was performed as described previously, with slight
modification (31). Briefly, cells were plated into 8-well chamber slides and
pretreated in serum-freemedium for 72 h containing 50MPDMP or 25
mU of PLC dissolved in DMSO or mock treated with equal amounts of
DMSO. At 48 h prior to infection, 3 M free gangliosides (GA1, GM1,
GM3, GD1a, GD1b, GT1b, GQ1b, and LSTc) was added to the medium.
Medium containing inhibitor and gangliosides was replaced every 24 h
prior to infection. Cells were infected and harvested as described above.
Cloning, expression, and purification of VP8* of rotavirus and P
domain of human norovirus. VP8* of human RV Dhaka6 strain (P[25]
genotype), and P particles of VA387 (GII-4) and VA207 (GII-9) human
norovirus (NV) strains were cloned, expressed, and purified as described
previously (4). The concentrations of purified RV VP8* and NV P do-
mains were determined by measuring absorbance at 280 nm.
Statistical analysis. Statistical analysis was performed by SPSS version
11.5.1 for Windows (SPSS, USA). A one-way analysis of variance
(ANOVA) was used to determine the statistical significance (P 0.05).
RESULTS
Carbohydrate moieties are required for attachment and infec-
tion of PSV. To determine whether PSV could require carbohy-
drate for binding and infection, carbohydrate moieties were re-
moved from cells by NaIO4, which destroys carbohydrate groups
without altering proteins or membranes (32). Pretreatment of
LLC-PK cells with various concentrations of NaIO4 markedly re-
duced the binding of AF-594-labeled PSV strain KS05151 (here
referred to simply as PSV) in a dose-dependent manner (Fig. 1A).
FIG 2 Binding of PSV to synthetic HBGAs. The binding ability of PSV strains (KS05151, KS05152, KS04105, or KS055217), the P domain of the human NV
VA207 (GII.9) and VA387 (GII.4) strains, VP8* of RV strain Dhaka6, and influenza virus A/PR/8/34 (H1N1) were determined using HRP-conjugated strepta-
vidin. Binding of HBGA was visualized using TMB and measured at 450 nm in three independent experiments. Error bars represent SD. The samples with
absorbance greater than 0.62 of the cutoff value, indicated by red dash line (3 standard deviations above the mean OD of the wells with negative control H1N1
influenza virus), were considered positive. ThemeanODs in the no-HBGA control and no-antigen control wells as a background are 0.04 and 0.06, respectively.
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To confirm the specificity of NaIO4 treatment, we used FCV and
EV70, both ofwhich could utilize terminal SA as a receptor (3, 25).
As a negative control, we used CVB3, which uses decay-accelerat-
ing factor (DAF) as a receptor (33). As expected, pretreatment of
cells with NaIO4 reduced the binding of carbohydrate-dependent
FCV and EV70 in a dose-dependent manner but had no effect on
binding of DAF-dependent CVB3 (data not shown). To more ac-
curately quantify the effect of NaIO4 treatment, radioisotope-la-
beled virus was incubated with cells after pretreatment with
NaIO4, and virus binding was determined by liquid scintillation
counting. Treatment of cells with 1 mM NaIO4 reduced the PSV
binding to 54% of the levels of mock-treated cells, whereas 5 mM
NaIO4 reduced its binding to 36% (Fig. 1B). As expected, NaIO4
treatment also resulted in a reduction in FCV and EV70 binding,
but no effect on CVB3 binding was observed (Fig. 1B). PSV infec-
tion was also reduced to 16% or 2% of the levels of cells pretreated
with only 1 mM or 5 mM NaIO4, respectively (Fig. 1C and D). A
similar reduction in infection was observed in NaIO4-treated cells
infected with known carbohydrate-binding viruses FCV and
EV70, although no effect was seen in DAF-binding CVB3 (Fig.
1D). These data indicated that carbohydrate moieties were re-
quired for the binding and infection of PSV.
HBGAs are not used for PSV attachment. Caliciviruses and
rotaviruses are known to use either SAs or HBGAs as receptors
FIG 3 PSV binding and infection are blocked byN-acetylneuraminic acid (NANA). (A) The effect of a soluble form of NANA on the binding of AF-594-labeled
PSV (MOI, 1,000 PFU/cell) to LLC-PK cells was examined by confocal microscopy. (B) The effect of soluble NANA, Gal, or 6=-SL on the binding of [35S]me-
thionine-cysteine-labeled PSV, EV70, FCV, or CVB3 (50,000 cpm) to each corresponding cell wasmeasured by liquid scintillation and expressed as a percentage
of the value for the mock-treated, virus-infected control. (C) The effect of NANA of permissive cells on the infectivity of PSV (MOI, 1 PFU/cell) was assessed by
immunofluorescence using monoclonal antibody specific for PSV capsid protein at 15 h postinfection. (D) The levels of PSV, EV70, FCV, or CVB3 antigen-
positive cells expressed as percentages of the mock-treated, virus-infected control were quantified from three independent fields of view. All experiments were
performed three independent times. Panels A and C show representative sets of results. Scale bars corresponded to 20m. Error bars indicate SD from triplicate
experiments. *, P 0.05; **, P 0.005.
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(4, 29, 34, 35). To examine whether PSV could use HBGAs as
receptors present on the cell surface, we performed synthetic
HBGA binding assay using PSV particles and various viruses as
specificity controls: P domains of NV strains VA207 (GII.9)
and VA387 (GII.4), human influenza virus strain PR8 (H1N1),
and VP8* of RV strain Dhaka6. Four strains of PSV showed no
binding to any synthetic HBGA, whereas control viruses
strongly bound the corresponding HBGA molecule (Fig. 2).
These data indicated that PSV had no binding affinity for
HBGAs as receptors.
SAs act as receptors for PSV. SA is an abundant carbohydrate
moiety on the cell surface (2) and acts as a receptor for many
viruses (1). FCV F9 and porcine sapovirus (PSaV) Cowden strains
are known to recognize terminal SA as a receptor (4, 25). Among
various SAs, however, binding of these viruses is blocked by
monosaccharide NANA but not by monosaccharide Gal or oligo-
saccharide 6=-SL (4, 25). To examine whether each SA could act as
a receptor for PSV, various concentrations (20 to 80 mM) of
monosaccharide (Gal and NANA) and oligosaccharide (6=-SL)
were incubated with AF-594-labeled or radiolabeled PSV or con-
trol viruses to analyze their impact on virus binding and infection.
PSV binding was reduced by NANA in a dose-dependent manner
(Fig. 3A and B). As expected, the binding of SA-dependent FCV
and EV70 was significantly blocked by NANA, whereas the bind-
FIG 4 PSV binding and infection require terminal SA. (A) Binding of AF-594-labeled PSV (MOI, 1,000 PFU/cell) was examined by confocal microscopy after
pretreating LLC-PK cells withNA or SS. (B) The effect of pretreament of NA or SS to each corresponding cell on the binding of [35S]methionine-cysteine-labeled
PSV, EV70, FCV, or CVB3 (50,000 cpm) was examined by liquid scintillation counting and expressed as a percentage of the value for the mock-treated,
virus-infected control. (C) The effect of NA or SS pretreatment of permissive cells on the infectivity of PSV (MOI, 1 PFU/cell) was assessed by immunofluores-
cence using monoclonal antibody specific for PSV capsid protein at 15 h postinfection. (D) The levels of PSV, EV70, FCV, or CVB3 antigen-positive cells
expressed as percentages of mock-treated, virus-infected cells were quantified from three independent fields of view. All experiments were performed three
independent times. Panels A and C show representative sets of results. The scale bars correspond to 20 m. Error bars indicate SD from triplicate experiments.
*, P 0.05; **, P 0.005.
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ing of DAF receptor-dependent CVB3 was unaffected (Fig. 3B).
Soluble NANA also significantly decreased the infection of PSV,
FCV, and EV70 but not CVB3 (Fig. 3C and D). In contrast, pre-
incubation with 6=-SL or Gal had no inhibitory effect on the bind-
ing and infection of PSV, FCV, EV70, or CVB3, regardless of the
concentration used (Fig. 3B and data not shown). Collectively,
these results demonstrated that PSV, like FCV and EV70, could
recognize SAs as receptors.
2,3-Linked SA is used forPSVattachment and infection. SA
is typically linked to galactose at the terminus of the oligosaccha-
ride by either 2,3 or 2,6 bonds or, in some cases, to an internal
SA by 2,8 bond (2). To further confirm the role of SA and to
examine the nature of the linkages required for PSV binding and
infection, cells were pretreated with NA (from Vibrio cholerae) to
cleave all 2,3-linked, 2,6-linked, and 2,8-linked SAs from un-
derlying glycans or with SS (from Streptococcus pneumoniae) to
cleave 2,3-linked SA only (25). Pretreatment of cells with NA
significantly reduced the binding of AF-594-labeled or radiola-
beled PSV and SA-dependent FCV as well as EV70, but not CVB3,
compared to that in mock-treated cells (Fig. 4A and B). NA also
inhibited the infection of cells by PSV, FCV, and EV70 but not
DAF-receptor dependent CVB3 (Fig. 4C and D). Pretreatment of
cells with SS reduced the binding and infection of PSV (Fig. 4). As
expected, SS treatment significantly reduced the binding of EV70,
FIG 5 PSV binding and infection require terminal 2,3-linked SA. (A) Binding of AF-594-labeled PSV (MOI, 1,000 PFU/cell) was examined by confocal
microscopy after pretreating LLC-PK cells with MAL or SNL. (B) The effect of pretreament of MAL or SNL to each corresponding cell on the binding of
[35S]methionine-cysteine-labeled PSV, EV70, FCV, and CVB3 strains (50,000 cpm) was examined by liquid scintillation counting and expressed as a percentage
of the value for the mock-treated, virus-infected control. (C) The effect of MAL or SNL pretreatment of permissive cells on the infectivity of PSV (MOI, 1
PFU/cell) was assessed by immunofluorescence using monoclonal antibody specific for PSV capsid protein at 15 h postinfection. (D) The levels of PSV, EV70,
FCV, or CVB3 antigen-positive cells expressed as percentages of the mock-treated, virus-infected cells were quantified from three independent fields of view. All
experiments were performed three independent times. Panels A andC show representative sets of results. The scale bars correspond to 20m. Error bars indicate
SD from triplicate experiments. *, P 0.05; **, P 0.005.
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which uses 2,3-linked SA as a receptor, but had no effect on the
binding or infection of 2,6-linked SA-dependent FCV or DAF-
dependent CVB3 (Fig. 4B and D). These data indicated that PSV
required 2,3-linked SA for binding and infection.
To confirm the above-described results, the effect of lectin pre-
incubation on virus binding and infection was examined. Cells
were pretreated with either MAL, with preferential binding to
2,3-linked SA, or SNL, with preferential binding to 2,6-linked
SA (25). Binding and infection of PSV and EV70were significantly
inhibited byMAL, whereas SNL had no effect (Fig. 5). In contrast,
binding and infection of FCV were dose dependently blocked by
SNL but not by MAL (Fig. 5). As expected, MAL and SNL did not
affect the binding and infection of DAF-dependent CVB3 (Fig. 5B
and D). Collectively, these data indicated that PSV used 2,3-
linked SA moieties for binding and infection.
Glycolipid-linked SA is required for PSV binding and in-
fection. SAs are attached to glycoproteins or glycosphingolip-
ids on the surface of permissive cells (2). Human RV strain Wa
uses glycosphinogolipid-containing SA moieties as receptors
(26), whereas EV70 and FCV recognize glycoproteins contain-
ing SA moieties as receptors (3, 25). To further define the na-
ture of the PSV receptor, LLC-PK cells were pretreated with
PDMP or PLC to inhibit the synthesis or the removal of SA-
containing glycolipids. Pretreatment of cells with PDMP or
PLC markedly reduced PSV binding and infection (Fig. 6). The
binding to and infection of pretreated cells by RV were also
FIG 6 PSV interacts with SA on glycolipid. (A) The binding of AF-594-labeled PSV (MOI, 1,000 PFU/cell) was examined by confocal microscopy after
pretreating LLC-PK cells with lipid metabolic inhibitors (PMDP and PLC) or proteases (trypsin and chymotrypsin). (B) Binding of [35S]methionine-cysteine-
labeled PSV, RV, or FCV to each permissive cell was measured by liquid scintillation and expressed as a percentage of the value for the mock-treated,
virus-infected cell control. (C) The effect of lipidmetabolic inhibitor or protease pretreatment of each permissive cell on the infectivity of PSV (MOI, 1 PFU/cell)
was assessed by immunofluorescence using a monoclonal antibody specific for PSV capsid protein at 15 h postinfection. (D) The levels of PSV, RV, or FCV
antigen-positive cells expressed as percentages of themock-treated, virus-infected control were quantified from three independent fields of view. All experiments
were performed three independent times. Panels A and C show representative sets results. The scale bars correspond to 20 m. Error bars indicate SD from
triplicate experiments. *, P 0.05; **, P 0.005.
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reduced, but no effect on the binding and infection of FCV was
observed (Fig. 6B and D).
To examine if PSV binding could require SA-containing gly-
coprotein moieties, cells were pretreated with trypsin or chymo-
trypsin proteases to examine their effect on PSV or RV binding
and infection. Pretreatment with trypsin or chymotrypsin had no
effect on the binding or infection of PSV or glycolipid-dependent
RV strainWa (Fig. 6). However, the binding and infection of FCV
were markedly reduced by both proteases (Fig. 6B and D). These
data indicated that PSV required SA-bearing glycolipids as recep-
tors.
GD1a acts as a receptor for PSV.To determinewhich ganglio-
sides were used for PSV binding and infection, cell surface gan-
gliosides were depleted by PMDP pretreatment and subsequently
reconstituted by the addition of various free gangliosides, includ-
ing GA, GM1, GM3, GD1a, GD1b, GQ1b, GT1b, and LSTc. Of
these gangliosides, GM1, GD1a, and GT1b possess one terminal
2,3-linked SA and the other gangliosides have no terminal 2,3-
linked SA, with or without internal 2,3- or 2,8-linked SA (36).
LSTc contains one terminal 2,6-linked SA. Reconstitution of
gangliosides in cells following the PMDP treatment revealed that
the PSV binding to and infection of LLC-PK cells could be re-
stored only by GD1a (Fig. 7) and not the others (data not shown).
PDMP treatment reduced the binding and infection of PSV to
FIG 7 PSV binding and infection are rescued by addition of GD1a. (A) The binding of AF-594-labeled PSV (MOI, 1,000 PFU/cell) was examined by confocal
microscopy after pretreating LLC-PK cells with PDMP for ganglioside depletion followed by the addition of various free gangliosides. (B) Binding of [35S]me-
thionine-cysteine-labeled PSV or RV (50,000 cpm) was measured by liquid scintillation counting after pretreating cells or not with PDMP for ganglioside
depletion, followed by the addition of various free gangliosides. The levels of bound virus were expressed as a percentage of the value for the mock-treated,
virus-inoculated control. (C) The effect of PDMP for ganglioside depletion followed by the addition of various free gangliosides on the infection of cells was
assessed by immunofluorescence using monoclonal antibody specific for PSV capsid protein at 15 h postinfection. (D) The levels of PSV or RV antigen-positive
cells expressed as a percentage of the values for themock-treated, virus-inoculated control were quantified from three independent fields of view. All experiments
were performed three independent times. Panels A and C show representative sets of results. The scale bars correspond to 20 m. Error bars indicate SD from
triplicate experiments. The asterisks in panels B andD indicate theP value (0.05) obtainedwhen comparing the PDMP treatment groupswith PDMP treatment
following ganglioside replenishment.
GD1a Ganglioside as a Porcine Sapelovirus Receptor
April 2016 Volume 90 Number 8 jvi.asm.org 4075Journal of Virology
 o
n
 August 3, 2016 by M
RC LAB O
F M
O
LECULAR BIO
LO
G
Y
http://jvi.asm.org/
D
ow
nloaded from
 
24% and 1% of the levels observed in mock-treated cells (Fig. 7B
and D). The decrease of binding and infection was rescued by the
addition of GD1a (Fig. 7) but not by other gangliosides (data not
shown). Binding and infection of the control RV strainWa, which
uses GM1a as a receptor (36), were also restored by the addition of
GM1a (Fig. 7B and D) but not by other gangliosides (data not
shown). These data suggest that PSV binds to both the terminal
and internal 2,3-linked SA moieties on GD1a and that the 2,8-
linked SA moiety on TG1b could interfere with binding of PSV.
DISCUSSION
Viruses initiate infection by binding to a specific receptor(s) on
the surface of susceptible host cells. Formany viruses, these recep-
tors are glycans (carbohydrates) linked to either protein or lipid
(1). Carbohydrates are major components of the cell surface and
extracellularmatrix (2). Interactions between viruses and host cell
receptors are key factors in the regulation of viral tropism, patho-
genesis, andhost range.Despite the recognition of sapeloviruses as
emerging porcine, simian, and avian pathogens, the nature of the
receptors used by members within the genus Sapelovirus has not
been determined. Here, we demonstrated that PSV used 2,3-
linked SA on GD1a glycolipid for binding and infection.
The SAs in the carbohydrates are ubiquitously displayed on the
surfaces of all mammalian cells and normally linked to underlying
sugar chains by 2,3 or 2,6 links to a galactose moiety or by 2,8
links to an internal SA (2). Among viruses within the family Picor-
naviridae, a number are known to use carbohydrates for attach-
ment and entry. For example, EV70 (3), equine rhinitis A virus
(37), and Theiler’s murine encephalomyelitis virus (38) use 2,3-
linked SAs. However, encephalomyocarditis virus, a member
within the genus Cardiovirus, recognizes 2,6-linked SAs (39).
Aside from carbohydrates, proteins have also been identified as
coreceptors. EV71 can utilize both 2,3- and 2,6-linked SAs in
addition to several protein receptors (40). Some echoviruses can
use CD55 and heparan sulfate (41). Here, we show that PSV uti-
lizes 2,3-linked SA on carbohydrates as a receptor. Preincuba-
tion of monosaccharide but not oligosaccharides significantly re-
duced binding and infection of not only SA-dependent control
viruses (FCV and EV70) but also PSV in cultured cells (3, 25).
Moreover, blocking 2,3 linkage by SS and MAL but not 2,6
linkage by SNL prevented binding and infection of PSV and con-
trol 2,3 linkag-dependent EV70 (3). Our observation that 2,3-
linked SA functioned in PSV attachment to host cells further con-
firmed the important role of carbohydrates in the attachment of
picornaviruses to target cells.
Cell surface carbohydrates (glycans) used as receptors for
many viruses are linked to either a protein or a lipid (1, 2). We
show that depletion of gangliosides from cell lipid membrane in-
hibited binding and infection of PSV, further suggesting the na-
ture of PSV receptor as a form of glycolipid. To confirm which
glycolipid is specifically recognized by PSV, cell surface glycolipids
were depleted and specific gangliosides were reconstituted on the
cell membrane. Reconstituting cell membranes with GD1a after
depletion of cell surface gangliosides restored the binding and
infection of PSV.However, other gangliosides hadno influence on
PSV binding and infection. Taken all together, our data show that
PSV recognizes 2,3-linked terminal SA on glycolipid GD1a as a
receptor for binding and infection. In addition, our observation
that chymotrypsin or trypsin treatment of cells had no effect on
virus infection suggests that cell surface-associated proteins do
not play accessory roles in PSV infection.
Caliciviruses within the Caliciviridae family and rotaviuses in
the Reoviridae use SA or HBGAs as receptors for their attachment
to cells (4, 29, 34, 35). These findingsmay imply that different PSV
strains may use HBGAs but not terminal SA as a receptor. In the
present study, however, all four PSV strains used showed no bind-
ing to HBGAs. From these data, it can be speculated that at least
four Korean PSVs may not utilize HBGAs as receptors.
The identified receptors for the generaNorovirus andRotavirus
are different depending on the genotypes and/or strains (8, 35).
For example, HBGAs act as the receptors for human and bovine
noroviruses (35, 42), whereas terminal SA functions as the recep-
tor for murine norovirus (31). Unlike the neuroinvasive English
PSV strain which causes severe nonsuppurative polioencephalo-
myelitis in the spinal cordwithout lesions in other tissues (43), the
Korean PSV strain was enteropathogenic (unpublished data).
These indicate that different PSV strains in Korea and other coun-
tries may recognize different receptor(s).
In conclusion, our work demonstrated that PSV could bind to
2,3-linked terminal SA moieties of GD1a ganglioside. These re-
sults will contribute to our understanding of the sapelovirus life
cycle and pathogenesis and to developing affordable, useful, and
efficient drugs for antisapelovirus therapy.
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